24小时热门版块排行榜    

查看: 433  |  回复: 1
本帖产生 1 个 翻译EPI ,点击这里进行查看

cclz110

银虫 (小有名气)

[求助] 急求翻译成中文,生物上的

FMS-like receptor tyrosine kinase-3(Flt3), a member of class III tyrosine kinase receptor family, is predominantly expressed in hematopoietic progenitor cells and plays an important role in the pathogenesis of acute myeloid leukemia (AML). Flt3 is expressed in blast cells of most patients with AML including wild-type and two forms of Flt3 mutations. These two mutations identified in the AML patients are internal tandem duplication (ITD) mutations in the juxtamembrane domain and point mutations (TKD) in the activation loop of the TKD. The relapse rates in the Flt3/ITD mutation AML patients are significantly increased and the overall survival rates decreased compared with the AML patients without the Flt3 mutation. So development of a drug inhibited both wide type and mutant Flt3 kinase could provide an effective way to treat AML.
已阅   关注TA 给TA发消息 送TA红花 TA的回帖

wangpei838

禁虫 (小有名气)

【答案】应助回帖

★
爱与雨下(金币+1): 2012-01-29 19:44:30
爱与雨下(金币+50): 2012-02-12 13:26:18
爱与雨下(翻译EPI+1): 2012-02-12 13:27:07
爱与雨下: bb代发! 2012-02-12 13:27:45
FMS样酪氨酸激酶3配体,属于Ⅲ型受体酪氨酸蛋白激酶家族,主要在造血干细胞中表达,是在急性髓性白血病(AML)方面研究广泛而深入的靶分子。Flt3在所有急性髓性白血病患者的原始细胞簇内都有所表达,其中包括野生型和两种Flt3变种。一种是近膜结构域的14、15外显子内部串联重复(ITD);另一种是激酶结构域的20外显子的点突变(TKD)。与没有Flt3突变的急性髓性白血病患者相比,Flt3/ITD突变的急性髓性白血病患者的复发率较高,总体治愈率较低。因此开发一种能够同时抑制野生型和变异型的Flt3激酶的药物是目前治疗髓性白血病的最有效的手段。
2楼2012-01-29 14:07:35
已阅   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 cclz110 的主题更新
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[硕博家园] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +6 zSbvVX9JFl9J 2026-11-09 9/450 2026-11-13 11:13 by Equinoxhua
[考博] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 TgvkbZZl9tqB 2026-11-11 6/300 2026-11-12 12:42 by ECLTXnJnRSXf
[考博] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +4 cdqGD6ftHmbl 2026-11-11 5/250 2026-11-12 12:28 by ECLTXnJnRSXf
[硕博家园] 售SCI一区文章,我:8.O.551.O.5.4,科目全,可伽急 +3 TgvkbZZl9tqB 2026-11-11 4/200 2026-11-12 12:28 by ECLTXnJnRSXf
[考研] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 Z7qfCsdIiD1T 2026-11-11 5/250 2026-11-12 11:44 by HajghKOMynmz
[基金申请] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +4 Z7qfCsdIiD1T 2026-11-11 5/250 2026-11-12 11:44 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8O.55.1.O.54,科目全,可伽急 +4 Z7qfCsdIiD1T 2026-11-10 4/200 2026-11-12 11:22 by HajghKOMynmz
[教师之家] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +4 Z7qfCsdIiD1T 2026-11-10 5/250 2026-11-12 11:14 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急 +7 czAiolzR0IJC 2026-11-10 9/450 2026-11-12 11:00 by HajghKOMynmz
[教师之家] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +4 czAiolzR0IJC 2026-11-10 7/350 2026-11-12 11:00 by HajghKOMynmz
[考博] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +4 czAiolzR0IJC 2026-11-10 6/300 2026-11-12 11:00 by HajghKOMynmz
[硕博家园] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +4 czAiolzR0IJC 2026-11-10 8/400 2026-11-12 10:49 by HajghKOMynmz
[考研] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +4 G2rhSvqvhNzl 2026-11-10 6/300 2026-11-12 10:36 by HajghKOMynmz
[公派出国] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +4 C6CRn66RYYXS 2026-11-10 8/400 2026-11-12 10:27 by HajghKOMynmz
[硕博家园] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 C6CRn66RYYXS 2026-11-10 6/300 2026-11-12 10:16 by HajghKOMynmz
[硕博家园] 售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急 +8 cqv1zKnzd7hr 2026-11-09 12/600 2026-11-12 09:32 by HajghKOMynmz
[考研] 售SCI一区文章,我:8O5.5.1.O5.4,科目全,可伽急 +8 cqv1zKnzd7hr 2026-11-09 12/600 2026-11-12 09:32 by HajghKOMynmz
[公派出国] 售SCI一区T0P文章,我:8.O.55.1.O.5.4,科目全,可+急 +3 gRND4NVAZ8VG 2026-11-11 3/150 2026-11-12 07:42 by HajghKOMynmz
[硕博家园] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 G2rhSvqvhNzl 2026-11-10 5/250 2026-11-12 06:14 by 9fOTqj074tIg
[基金申请] 售SCI一区T0P文章,我:8.O.55.1.O.54,科目齐全,可+急 +5 FChKX8meu1ds 2026-11-09 7/350 2026-11-12 05:30 by 9fOTqj074tIg
信息提示
请填处理意见